Report examines ROI on personalized medicine

Personalized medicine--which uses genetic data to provide specialized medicine for individual patients--is slowly moving into the healthcare mainstream, though only a few practical applications exist to date. However, when it does become practical, it may be a financial blessing. A new report by the Deloitte Center for Health Solutions finds that personalized medicine could provide significant ROI for all of the key stakeholders in the U.S. healthcare system. Article

Suggested Articles

Healthcare’s RCM processes are in dire need of a 21st-century update that delivers greater automation and real-time transparency.

Amazon's PillPack and Surescripts, owned by CVS Health and Express Scripts, are in a dispute over access to patient medication history data.

Presidential candidate Kamala Harris wants to get rid of the tax break drug companies get for direct-to-consumer advertising.